Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
Dr. Rachael Wolters, DVM, PhD, is an expert in the field of antiviral monoclonal antibodies. She earned her Doctor of Veterinary Medicine (DVM) from the University of Tennessee and her PhD from Vanderbilt University, where she conducted her research in the laboratory of Dr. James Crowe. During her time at Vanderbilt, Dr. Wolters focused on the discovery and characterization of broadly neutralizing human monoclonal antibodies against influenza type B virus. Currently, Dr. Wolters holds a Research Assistant Professor position at the Oregon National Primate Research Center (ONPRC) in the Department of Pathobiology and Immunology, collaborating with Dr. Ann Hessell. Her work at ONPRC centers on developing and enhancing antiviral human monoclonal antibodies, with a particular focus on their application in HIV-1 immunology and other viral pathogens. Her contributions have been recognized through various awards and grants, including an early investigator NIH K01 grant.
In her talk, Dr. Wolters will delve into the past, present, and future of antiviral monoclonal antibodies, providing insights from her extensive research experience and outlining potential future directions in this rapidly evolving field.
This seminar will be in person only
